Progress in the Development of an HIV-1 Vaccine (Q45147943)

10 December 2017

1 reference

title

Progress in the development of an HIV-1 vaccine (English)

1 reference

10 December 2017

Progress in the Development of an HIV-1 Vaccine (English)

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

27 December 2024

1 reference

1

Letvin NL

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

10 December 2017

19 June 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9632379

full work available at URL

27 December 2024

https://www.science.org/doi/pdf/10.1126/science.280.5371.1875

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

27 December 2024

1 reference

10 December 2017

volume

280

1 reference

10 December 2017

issue

5371

1 reference

10 December 2017

page(s)

1875-1880

1 reference

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

10 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

27 December 2024

3

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

27 December 2024

4

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

27 December 2024

5

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.

27 December 2024

6

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

27 December 2024

7

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes

27 December 2024

11

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus

27 December 2024

12

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

27 December 2024

13

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

27 December 2024

15

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Pathogenic diversity of simian immunodeficiency viruses

27 December 2024

17

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys

27 December 2024

20

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

27 December 2024

21

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

27 December 2024

23

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus

27 December 2024

26

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus

27 December 2024

27

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

27 December 2024

29

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Anti-cell antibody in macaques

27 December 2024

31

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120

27 December 2024

33

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

27 December 2024

34

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines

27 December 2024

35

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Core structure of gp41 from the HIV envelope glycoprotein

27 December 2024

37

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

27 December 2024

39

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Recombinant Virus Vaccine-Induced SIV-specific CD8 + Cytotoxic T Lymphocytes

27 December 2024

40

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

27 December 2024

41

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

27 December 2024

42

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

27 December 2024

43

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus

27 December 2024

47

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

27 December 2024

DNA vaccines

50

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

27 December 2024

51

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells

27 December 2024

52

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

27 December 2024

54

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.280.5371.1875

27 December 2024

Identifiers

1 reference

10 December 2017

1 reference